CA
INSM icon

CoreCap Advisors’s Insmed INSM Stock Holding History

CoreCap Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$746 Buy
7
+5
+250% +$605 ﹤0.01% 2762
2026
Q1 		$327 Sell
2
-155
-99% -$23.8K ﹤0.01% 2709
2025
Q4 		$27.3K Buy
+157
New +$28.6K ﹤0.01% 1563
2025
Q2 		– Sell
-9
Closed -$687 – 2998
2025
Q1 		$687 Buy
+9
New +$688 ﹤0.01% 2606

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

CoreCap Advisors's INSM Position: Q2 2026 in Review

CoreCap Advisors increased its Insmed (INSM) stake by 250% in Q2 2026, buying an estimated $605 and bringing the position to 7 shares worth $746. The position accounts for ﹤0.01% of the portfolio, ranked #2762.

CoreCap Advisors first reported a position in INSM in Q1 2025 and has held it in 4 quarters since. The position peaked at $27.3K in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • CoreCap Advisors held 7 shares of Insmed worth $746 as of Q2 2026.
  • CoreCap Advisors bought 5 Insmed shares in Q2 2026, an estimated $605.
  • Insmed made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2762 holding.
  • CoreCap Advisors first reported a position in Insmed in Q1 2025 and has held it in 4 quarters since.
  • CoreCap Advisors's Insmed position peaked at $27.3K in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.